Institute for Advancing Medical Innovation Trailblazer Awards

Frontiers Institute for Advancing Medical Innovation (IAMI) Trailblazer Awards support four targeted areas of clinical and translational research: Experimental Therapeutic trials, Drug and Medical Device Development, Biomarker Discovery and Validation, and Entrepreneurship activities consistent with IAMI's mission.

Applicants may request up to $25,000; lesser amounts are acceptable and encouraged especially if the Frontiers IAMI Trailblazer Award can be used to match or leverage additional resources.

View the full RFA

A goal of Frontiers' funding agency, the National Center for Advancing Translational Sciences, is "to get more treatments to more patients more quickly". The Frontiers IAMI Trailblazer Award addresses this goal by providing funds to help investigators carry out early-stage, feasibility studies to identify drug, diagnostic, and medical device product development opportunities. Data generated from successful studies will be disseminated in impactful publications and support successful extramural funding applications.

Frontiers IAMI Trailblazer Awards support multidisciplinary translational research projects that address all diseases and include academic disciplines such as chemistry, molecular biology, medicine, pharmacy, allied health professions, nursing, veterinary medicine, and other areas that impact clinical and translational science.

Faculty investigators from all Frontiers institutions are invited to apply. All funding decisions and actual start dates for Trailblazer Awards are contingent upon receipt of the NCATS Notice of Award for Year 5 funding.

Review full RFA for all dates.

Any questions regarding Frontiers IAMI Trailblazer Awards should be directed to frontiers-info@kumc.edu or 913-588-6290.